ESSA PHARMA INC: Diferență între versiuni

The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
(Pagină nouă: Pagina dedicata companiei ESSA PHARMA INC listata cu simbolul US.EPIX ==Descriere companie== ESSA Pharma Inc. (www.essapharma.com) is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The Company is evaluating EPI...)
 
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
 
Linia 1: Linia 1:
Pagina dedicata companiei ESSA PHARMA INC listata cu simbolul US.EPIX
Pagina dedicata companiei ESSA [[PHARMA]] INC listata cu simbolul US.EPIX


==Descriere companie==
==Descriere companie==
ESSA Pharma Inc. (www.essapharma.com) is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The Company is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.
[[ESSA Pharma]] Inc. (www.essapharma.com) is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The Company is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.


==Grafic actiuni companie==
==Grafic actiuni companie==
Utilizator anonim